Respiratory Disposables Market Size, Share & Trends Analysis Report By Product (Laryngoscope, Tubes, Breathing Bag, Masks, Resuscitator, Others), By Patient Group (Neonatal and Pediatric, Adult, Geriatric), By End-User (Hospitals, Nursing Homes, and Clinics, Trauma Centers, Homecare) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Market Overview

The global respiratory disposables market size was valued at USD 1.49 billion in 2021. It is projected to reach USD 3.4 billion by 2030, growing at a CAGR of 9.6 % during the forecast period (2022–2030).

Respiratory disposables are used to identify hemostatic flaws that result in excessive bleeding. When there is damage, the body uses hemostasis as a protective measure. Along with aiding in treatment, it aids in diagnosing the true origin of these disorders. Respiratory disposables connect respiratory equipment like ventilators, nebulizers, and oxygen therapy devices. Disposable resuscitators, disposable tubes, oxygen masks, and other accessories are respiratory disposables.

During procedures, healthcare professionals use disposable respiratory protective devices to shield them from transmitting microorganisms, bodily fluids, and foreign particles. Respiratory disposables treat respiratory conditions like asthma, sleep apnea, and chronic obstructive pulmonary disease (COPD). Along with infection prevention, they also reduce the financial burden placed on hospitals, save time, and increase demand.

Market Dynamics

Global respiratory disposables market drivers

Increasing respiratory illnesses

An increase in respiratory disease incidence affecting the respiratory system is anticipated to aid the industry's growth in the upcoming years. By 2030, there will be 38% more lung cancer cases worldwide. Additionally, it is anticipated that the enormous increase in the incidence of respiratory diseases will increase the demand for respiratory disposables. The global market for respiratory disposables is forecasted to grow due to the rising prevalence of respiratory conditions like asthma and COPD during the anticipated period. For instance, the Asthma and Allergy Foundation of America (AAFA) estimates that over 25 million Americans have asthma, which is roughly one in every 13 people. It is the most prevalent chronic illness in kids. Additionally, there are currently 5.1 million children under 18 who suffer from asthma.

Global respiratory disposables market restraint

Higher rates of respiratory disposables failure

The COVID-19 pandemic caused a shortage of disposable N95 respirators, forcing healthcare organizations to utilize these masks more frequently than planned. However, due to the lack of sufficient research on the continued efficacy of disposable masks, the manufacturer only advised single-use and discouraged further use of the same. When evaluating the quality of respiratory disposables, healthcare professionals realized that the seal integrity of their disposable respirators was poor, making them unusable after one use. Although respiratory disposables are available for single-use and multiple uses, they are seen to lose their quality after repeated use. Additionally, due to clinical practice reuse, disposable N95 masks have recorded notable failure rates.

Global respiratory disposables market opportunities

Rising number of viruses attacking the respiratory system

Bocavirus, the common cold, coronavirus, metapneumovirus, parainfluenza virus, respiratory adenovirus, respiratory syncytial virus, and rhinovirus are among the respiratory viruses that are in the outbreak. The most frequent disease-causing agents in humans are respiratory viruses, which have a significant global impact on morbidity and mortality. All over the world, common respiratory pathogens from various virus families are well-suited to effective person-to-person transmission. The respiratory, respiratory syncytial, parainfluenza, metapneumovirus, rhinovirus, coronavirus, adenovirus, and bocavirus are the respiratory viruses that circulate most frequently as endemic or epidemic agents. Since respiratory disposables help to stop the spread of infections from person to person, it is anticipated that the outbreak of these viruses will significantly boost the market for respiratory disposables.

Regional Analysis

The global respiratory disposables market is bifurcated into four regions, namely North America, Europe, Asia-Pacific, and LAMEA.

North america dominates the global market

North America is the most significant shareholder in the global respiratory disposables market and is expected to grow at a CAGR of 9.3% during the forecast period. The United States, Canada, and Mexico are the three major North American nations in the report. Due to the government's emphasis on enhancing the healthcare infrastructure, North America has a significant growth opportunity. Due to the increased demand for maintaining a higher standard of living, the availability of skilled workers, and significant market players, the U.S. gained the highest revenue share. In addition, rising respiratory disease incidences, such as lung cancer, asthma, and COPD, rising disposable demand for respiratory products, and cutting-edge healthcare facilities with skilled medical staff all play a significant role in the market's expansion.

Europe is expected to grow at a CAGR of 9.5% generating USD 989.82 million during the forecast period. In 2021, Europe accounted for 29.3% of the global market for respiratory disposables. The demand for better respiratory disposables and the significant presence of key players like Medtronic Plc. and Air Liquide S.A. are expected to drive steady growth in the respiratory disposables market in European nations during the forecast period. Additionally, the market is expected to grow as more healthcare professionals use respiratory disposables to treat respiratory diseases. The key growth drivers in Europe include the rise in respiratory disease incidence, an increase in air pollution, and new product innovations in respiratory disposables. Other significant growth drivers of the Europe market include the presence of developed healthcare infrastructure and the accessibility of qualified professionals.

Asia-Pacific is expected to see the fastest market growth during the projected period due to its huge population base, rise in the efficacy of respiratory disposables, favorable reimbursement policies associated with respiratory disposables, and improvement in healthcare infrastructure. Additionally, one of the factors contributing to the market's significant growth is the rise in healthcare professionals' awareness of the advantages and uses of respiratory disposables. A sharp increase in leading manufacturers' attention to geographical expansion in developing Asia-Pacific nations to seize high growth opportunities spurs market expansion. China is also expected to grow due to the highest patient population, a significant increase in demand for cutting-edge medical facilities, and an increase in R&D activities in the healthcare sector in the region.

The global respiratory disposables market in LAMEA held 8.90% of the market share and is predicted to proliferate. Due to a lack of hospitals offering cutting-edge medical procedures and a shortage of qualified medical staff, the LAMEA region's market is still in its infancy. LAMEA is an emerging market that is anticipated to offer lucrative growth opportunities for key players due to the expansion of the target population, the surge in demand for respiratory disposables, and improvements in the healthcare infrastructure. Additionally, the rise in patients with respiratory illnesses in LAMEA fuels the use of respiratory disposables, which propels market expansion.

Segmental Analysis

The global respiratory disposables market is segmented by product, patient group, and end-user.

Based on product, the global market is bifurcated into laryngoscopes, tubes, breathing bags, masks, resuscitators, and others.

The resuscitators segment is the highest contributor to the market and is expected to grow at a CAGR of 8.9% during the forecast period. A resuscitator is a machine that uses positive pressure to expand a person's lungs while unconscious and not breathing to keep them oxygenated. There are three basic types of resuscitators on the market, including a manual version known as a bag valve mask that consists of a mask and a sizable plastic bulb that is squeezed by hand to provide oxygen either with ambient air or with the help of supplemental oxygen from a high-pressure tank. An oxygen-powered resuscitator is the third kind. These can either be operated automatically or manually and are powered by pressurized gas that a regulator distributes.

A laryngoscope is a tool that helps with tracheal visualization during intubation and comprises a blade and a handle with a battery holder. Additionally, batteries are included, which are used to power the light bulb in the blade. Traditional laryngoscopes come in models with interchangeable blades. The laryngoscope handle is hollow and cylindrical and houses the lighting batteries. Before using the blade, the handle must be attached during the intubation procedure. This accessory completes the circuit of the light/bulb at the end of the blade tip, making it shine brighter while the blade is being illuminated.

Based on patient groups, the global market is bifurcated into neonatal and pediatric, adult, and geriatric.

The geriatric segment owns the highest market share and is expected to grow at a CAGR of 9.4% during the forecast period. Due to a weakened immune system brought on by the beginning of cell degeneration, older people are most vulnerable to respiratory diseases. Among the geriatric population, respiratory tract infections, tuberculosis, chronic obstructive pulmonary diseases, and bronchial asthma are prevalent respiratory diseases. However, the course may differ in the elderly due to frequent comorbidities as well as the physiologic process of aging. It is anticipated that an increase in patients over 60 who have respiratory diseases will significantly fuel the segment's growth.

Patients from the stage of the human lifespan, when full physical and intellectual maturity has been attained, make up the adult patient group. The age range for adult patients is from over 18 to over 60. The adult population is susceptible to several respiratory conditions that can be divided into four groups: parenchymal lung diseases, occupational lung diseases, chronic diseases, asthma, chronic obstructive pulmonary disease (COPD), and acute diseases like pneumonia and influenza.

Based on end-user, the global market is bifurcated into hospitals, nursing homes, and clinics, trauma centers, and home care.

The hospitals, nursing homes, and clinics segment is the highest contributor to the market and is expected to grow at a CAGR of 9.1% during the forecast period. Institutions like hospitals, nursing homes, and clinics offer diagnostic, follow-up care, and treatment to patients with various acute and chronic illnesses and those who have been injured or have other similar conditions. These healthcare facilities are the most favored because they can accommodate more inpatients and outpatients than others. Additionally, hospitals' increased investment capacity for better respiratory disposables during the forecast period will likely boost the segment's growth. The main drivers of market growth are the rise in respiratory disease prevalence and advancements by R&D in the healthcare industry. Additionally, major players are concentrating on developing cutting-edge technologies to make respiratory disposables-related products available.

Homecare refers to services offered to people of all ages inside a home. A person who is aging and requires assistance to live independently, is managing chronic health conditions, is recovering from a medical setback, or has special needs or a disability can all benefit from in-home care services. Depending on a person's needs, professional caregivers like nurses, aids, and therapists offer short or long-term care in the home.

Recent Developments

• October 2022- Hamilton Medical offered comfort to patients with an NIV mask portfolio. For patients, Hamilton Medical and Pulmodyne partnered to offer various interfaces.
• August 2022- ResMed pledged to invest EUR 30 million in Irish research and development. According to a ResMed study, COPD is the third-deadliest disease in the world and affects over 480 million people.